Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had revenue of $357.00K in the quarter ending September 30, 2024, a decrease of -12.07%. This brings the company's revenue in the last twelve months to $1.60M, down -23.42% year-over-year. In the year 2023, Northwest Biotherapeutics had annual revenue of $1.93M with 14.80% growth.

• Revenue (ttm): 1.60M
• Revenue Growth: -23.42%
• P/S Ratio: 196.45
• Revenue / Employee: 63.84K
• Employees: 25
• Market Cap: 341.69M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.93M	249.00K	14.80%
Dec 31, 2022	1.68M	678.00K	67.46%
Dec 31, 2021	1.01M	-286.00K	-22.15%
Dec 31, 2020	1.29M	-1.12M	-46.43%
Dec 31, 2019	2.41M	2.00M	484.95%